OMB Home White House Website

Agency:    Department of Defense--Military
Bureau:    Research, Development, Test, and Evaluation
Account:    Research, development, test, and evaluation, Army (21-2040)
Certifying Official:    Deputy Comptroller Program/Budget
Contact Information:    http://WWW.DOD.GOV   703-697-5131

1 recipient will receive $4,120,000. This is a continuing earmark.
Year Enacted: 2005
Description: The overall goal of the proposed research is to develop, test, and seek FDA approval for the versaHSDI instrument: a novel fluorescence and reflectance spectroscopic cancer imaging device based on a versatile, modular design. The versaHSDI system will facilitate early detection of neoplasia in a variety of organs, through use of interchangeable imaging probe modules adapted to endoscopic and/or superficial detection needs. The initial focus of the versaHSDI effort will be to detect colorectal cancer with subsequent development targeting nonmelanoma skin cancer detection. Our approach and effort will leverage experience gained by developing Science & Technology International s hyperspectral diagnostic imaging (HSDI ) system for detecting cervical cancer.
Beneficiary/Recipient Amount ($K) Program Type Address
Science & Technology International $4,120 For-Profit
Honolulu, HI
Source: Appropriations Report Language - Conference
Reference: 108-622
Location: Line 29, Page 256
Citation Excerpt: HSDI

Last Modified: 16-Apr-2007

Federal Register    |   Jobs at OMB   |   FOIA   |  OMB Locator   |   |   Accessibility   |   Privacy Policy   |   Site Search   |   Help